Cardiostimulatory and antiarrhythmic activity of tubulin-binding agents

Theodore Lampidis, Despina Kolonias, Niramol Savaraj, Robert W. Rubin

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Rhythmic, spontaneously pulsating cardiac cells cultured from newborn rats are immediately stimulated to beat faster by addition of a number of tubulin-binding agents but not by their non-tubulin-binding analogues. The tubulin-binding agents tested include vinblastine, vincristine, navelbine, two analogs of vinblastine (S12362 and S12363), nocodazole, colchicine, and podophylotoxin. In addition to binding tubulin, all of the above agents also depolymerize microtubules. In contrast, taxol, a tubulin-binding agent that stabilizes microtubules, does not stimulate cardiac cells. Moreover, the immediate and ensuing cardiac stimulation by vinblastine at 0.05 μg/ml is completely blocked by pre- and cotreatment with taxol at 1.0 μg/ml. The time necessary to reverse the cardiostimulatory effect of vinblastine is significantly longer than that required for nocodazole, further implicating depolymerization of microtubules in the cardiac activity of these agents. All of the tubulin-binding agents tested (including taxol) also immediately reverse adriamycin-induced arrhythmias. By using a monoclonal antibody to α-tubulin, typical filamentous microtubules are visualized in cardiac muscle and cocultured non-muscle cells by immunofluorescence. When cells are treated for 2 hr with vinblastine at 0.05 μg/ml, fluorescence is detected in cross-striated patterns in cardiac muscle cells. Overall, these data open the possibility of uncovering an additional relationship between cytoskeletal elements (other than actin and myosin) and the contractility of cardiac muscle. They also suggest an alternative mechanism for affecting cardiac cell function in vitro (namely, by tubulin-binding agents). If these agents are shown to be cardioactive in vivo, they may provide another approach to the treatment and management of cardiac arrhythmias.

Original languageEnglish
Pages (from-to)1256-1260
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume89
Issue number4
StatePublished - Feb 15 1992

Fingerprint

Tubulin
Vinblastine
S 12363
Microtubules
Paclitaxel
Nocodazole
Cardiac Arrhythmias
Cardiac Myosins
Colchicine
Vincristine
Cardiac Myocytes
Doxorubicin
Fluorescent Antibody Technique
Actins
Cultured Cells
Myocardium
Fluorescence
Monoclonal Antibodies

Keywords

  • Microtubules
  • Navelbine
  • Podophylotoxin
  • Taxol
  • Vinblastine

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Cardiostimulatory and antiarrhythmic activity of tubulin-binding agents. / Lampidis, Theodore; Kolonias, Despina; Savaraj, Niramol; Rubin, Robert W.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 89, No. 4, 15.02.1992, p. 1256-1260.

Research output: Contribution to journalArticle

@article{93fcf2e918a84f0b8cb9b59a66378bea,
title = "Cardiostimulatory and antiarrhythmic activity of tubulin-binding agents",
abstract = "Rhythmic, spontaneously pulsating cardiac cells cultured from newborn rats are immediately stimulated to beat faster by addition of a number of tubulin-binding agents but not by their non-tubulin-binding analogues. The tubulin-binding agents tested include vinblastine, vincristine, navelbine, two analogs of vinblastine (S12362 and S12363), nocodazole, colchicine, and podophylotoxin. In addition to binding tubulin, all of the above agents also depolymerize microtubules. In contrast, taxol, a tubulin-binding agent that stabilizes microtubules, does not stimulate cardiac cells. Moreover, the immediate and ensuing cardiac stimulation by vinblastine at 0.05 μg/ml is completely blocked by pre- and cotreatment with taxol at 1.0 μg/ml. The time necessary to reverse the cardiostimulatory effect of vinblastine is significantly longer than that required for nocodazole, further implicating depolymerization of microtubules in the cardiac activity of these agents. All of the tubulin-binding agents tested (including taxol) also immediately reverse adriamycin-induced arrhythmias. By using a monoclonal antibody to α-tubulin, typical filamentous microtubules are visualized in cardiac muscle and cocultured non-muscle cells by immunofluorescence. When cells are treated for 2 hr with vinblastine at 0.05 μg/ml, fluorescence is detected in cross-striated patterns in cardiac muscle cells. Overall, these data open the possibility of uncovering an additional relationship between cytoskeletal elements (other than actin and myosin) and the contractility of cardiac muscle. They also suggest an alternative mechanism for affecting cardiac cell function in vitro (namely, by tubulin-binding agents). If these agents are shown to be cardioactive in vivo, they may provide another approach to the treatment and management of cardiac arrhythmias.",
keywords = "Microtubules, Navelbine, Podophylotoxin, Taxol, Vinblastine",
author = "Theodore Lampidis and Despina Kolonias and Niramol Savaraj and Rubin, {Robert W.}",
year = "1992",
month = "2",
day = "15",
language = "English",
volume = "89",
pages = "1256--1260",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "4",

}

TY - JOUR

T1 - Cardiostimulatory and antiarrhythmic activity of tubulin-binding agents

AU - Lampidis, Theodore

AU - Kolonias, Despina

AU - Savaraj, Niramol

AU - Rubin, Robert W.

PY - 1992/2/15

Y1 - 1992/2/15

N2 - Rhythmic, spontaneously pulsating cardiac cells cultured from newborn rats are immediately stimulated to beat faster by addition of a number of tubulin-binding agents but not by their non-tubulin-binding analogues. The tubulin-binding agents tested include vinblastine, vincristine, navelbine, two analogs of vinblastine (S12362 and S12363), nocodazole, colchicine, and podophylotoxin. In addition to binding tubulin, all of the above agents also depolymerize microtubules. In contrast, taxol, a tubulin-binding agent that stabilizes microtubules, does not stimulate cardiac cells. Moreover, the immediate and ensuing cardiac stimulation by vinblastine at 0.05 μg/ml is completely blocked by pre- and cotreatment with taxol at 1.0 μg/ml. The time necessary to reverse the cardiostimulatory effect of vinblastine is significantly longer than that required for nocodazole, further implicating depolymerization of microtubules in the cardiac activity of these agents. All of the tubulin-binding agents tested (including taxol) also immediately reverse adriamycin-induced arrhythmias. By using a monoclonal antibody to α-tubulin, typical filamentous microtubules are visualized in cardiac muscle and cocultured non-muscle cells by immunofluorescence. When cells are treated for 2 hr with vinblastine at 0.05 μg/ml, fluorescence is detected in cross-striated patterns in cardiac muscle cells. Overall, these data open the possibility of uncovering an additional relationship between cytoskeletal elements (other than actin and myosin) and the contractility of cardiac muscle. They also suggest an alternative mechanism for affecting cardiac cell function in vitro (namely, by tubulin-binding agents). If these agents are shown to be cardioactive in vivo, they may provide another approach to the treatment and management of cardiac arrhythmias.

AB - Rhythmic, spontaneously pulsating cardiac cells cultured from newborn rats are immediately stimulated to beat faster by addition of a number of tubulin-binding agents but not by their non-tubulin-binding analogues. The tubulin-binding agents tested include vinblastine, vincristine, navelbine, two analogs of vinblastine (S12362 and S12363), nocodazole, colchicine, and podophylotoxin. In addition to binding tubulin, all of the above agents also depolymerize microtubules. In contrast, taxol, a tubulin-binding agent that stabilizes microtubules, does not stimulate cardiac cells. Moreover, the immediate and ensuing cardiac stimulation by vinblastine at 0.05 μg/ml is completely blocked by pre- and cotreatment with taxol at 1.0 μg/ml. The time necessary to reverse the cardiostimulatory effect of vinblastine is significantly longer than that required for nocodazole, further implicating depolymerization of microtubules in the cardiac activity of these agents. All of the tubulin-binding agents tested (including taxol) also immediately reverse adriamycin-induced arrhythmias. By using a monoclonal antibody to α-tubulin, typical filamentous microtubules are visualized in cardiac muscle and cocultured non-muscle cells by immunofluorescence. When cells are treated for 2 hr with vinblastine at 0.05 μg/ml, fluorescence is detected in cross-striated patterns in cardiac muscle cells. Overall, these data open the possibility of uncovering an additional relationship between cytoskeletal elements (other than actin and myosin) and the contractility of cardiac muscle. They also suggest an alternative mechanism for affecting cardiac cell function in vitro (namely, by tubulin-binding agents). If these agents are shown to be cardioactive in vivo, they may provide another approach to the treatment and management of cardiac arrhythmias.

KW - Microtubules

KW - Navelbine

KW - Podophylotoxin

KW - Taxol

KW - Vinblastine

UR - http://www.scopus.com/inward/record.url?scp=0026571611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026571611&partnerID=8YFLogxK

M3 - Article

VL - 89

SP - 1256

EP - 1260

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 4

ER -